<?xml version="1.0" encoding="utf-8" ?><rss version="2.0"><channel><title>Bing: Programming Computer Vision Avatar</title><link>http://www.bing.com:80/search?q=Programming+Computer+Vision+Avatar</link><description>Search results</description><image><url>http://www.bing.com:80/s/a/rsslogo.gif</url><title>Programming Computer Vision Avatar</title><link>http://www.bing.com:80/search?q=Programming+Computer+Vision+Avatar</link></image><copyright>Copyright © 2026 Microsoft. All rights reserved. These XML results may not be used, reproduced or transmitted in any manner or for any purpose other than rendering Bing results within an RSS aggregator for your personal, non-commercial use. Any other use of these results requires express written permission from Microsoft Corporation. By accessing this web page or using these results in any manner whatsoever, you agree to be bound by the foregoing restrictions.</copyright><item><title>OpenEvidence</title><link>https://www.openevidence.com/</link><description>America's Official Medical Knowledge Platform. OpenEvidence is the leading medical platform for healthcare professionals, featuring answers grounded in peer-reviewed research from NEJM, JAMA, NCCN, Cochrane, and more.</description><pubDate>Mon, 01 Jun 2026 06:00:00 GMT</pubDate></item><item><title>About | OpenEvidence</title><link>https://www.openevidence.com/about</link><description>America's Official Medical Knowledge Platform. OpenEvidence is the leading medical platform for healthcare professionals, featuring answers grounded in peer-reviewed research from NEJM, JAMA, NCCN, Cochrane, and more.</description><pubDate>Mon, 01 Jun 2026 17:56:00 GMT</pubDate></item><item><title>National Organization for Rare Disorders and OpenEvidence Partner to ...</title><link>https://www.openevidence.com/announcements/national-organization-for-rare-disorders-and-openevidence-partner-to-bring-ai-powered-rare-disease-resources-to-clinicians-and-patients-worldwide</link><description>NORWELL, Mass., and MIAMI, Fla. (March 12, 2026) - The National Organization for Rare Disorders (NORD®) and OpenEvidence today announced a new partnership to expand access to trusted, expert-reviewed rare disease information for clinicians, patients and families.</description><pubDate>Mon, 01 Jun 2026 17:28:00 GMT</pubDate></item><item><title>Ask Overview | User Guide | OpenEvidence</title><link>https://www.openevidence.com/user-guide/ask-overview</link><description>OpenEvidence is the most widely used medical AI among verified U.S. physicians, with over 100 million AI-powered clinical consultations completed to date. OpenEvidence gives comprehensive, evidence-based answers to clinical questions — grounded in peer-reviewed literature from NEJM, JAMA, NCCN, Cochrane, and more. Unlike general-purpose AI, OpenEvidence is built specifically for clinical ...</description><pubDate>Mon, 01 Jun 2026 17:42:00 GMT</pubDate></item><item><title>NCCN and OpenEvidence Collaborate to Bring Clinical Oncology Guidelines ...</title><link>https://www.openevidence.com/announcements/nccn-and-openevidence-collaborate-to-bring-clinical-oncology-guidelines-to-medical-ai</link><description>PLYMOUTH MEETING, PA, and MIAMI, FL — Nov 5, 2025 — The National Comprehensive Cancer Network® (NCCN®) and OpenEvidence, the leading AI-powered medical search and decision-support platform, today announced a licensing agreement to make NCCN’s trusted, evidence-based oncology guidelines accessible through OpenEvidence’s medical artificial intelligence technology. Through this ...</description><pubDate>Sun, 31 May 2026 02:20:00 GMT</pubDate></item><item><title>Announcements - OpenEvidence</title><link>https://www.openevidence.com/announcements</link><description>America's Official Medical Knowledge Platform. OpenEvidence is the leading medical platform for healthcare professionals, featuring answers grounded in peer-reviewed research from NEJM, JAMA, NCCN, Cochrane, and more.</description><pubDate>Sun, 31 May 2026 14:51:00 GMT</pubDate></item><item><title>OpenEvidence 2.0 Now Available</title><link>https://www.openevidence.com/announcements/openevidence-20</link><description>We are excited to announce OpenEvidence 2.0. In addition to medical search, OpenEvidence now fully supports administrative and clinical workflow use cases, including:</description><pubDate>Mon, 01 Jun 2026 18:03:00 GMT</pubDate></item><item><title>OpenEvidence, the Fastest-Growing Application for Physicians in History ...</title><link>https://www.openevidence.com/announcements/openevidence-the-fastest-growing-application-for-physicians-in-history-announces-dollar210-million-round-at-dollar35-billion-valuation</link><description>OpenEvidence helps clinicians make high-stakes clinical decisions at the point of care. OpenEvidence is redefining evidence-based medicine in real-time and transforming how frontline healthcare providers access, evaluate, and apply the world's medical knowledge. OpenEvidence is actively used across more than 10,000 hospitals and medical centers nationwide and by more than 40% of physicians in ...</description><pubDate>Sun, 31 May 2026 04:21:00 GMT</pubDate></item><item><title>Mount Sinai Health System Collaborates with OpenEvidence to Provide ...</title><link>https://www.openevidence.com/announcements/mount-sinai-health-system-collaborates-with-openevidence-to-provide-evidence-based-knowledge-within-electronic-medical-record</link><description>Implementing OpenEvidence provides our pharmacists, nurses, and physicians with a unified, trusted platform for evidence-based decision-making, reinforcing our mission to lead the way in safe and effective clinical AI," said Nicholas Gavin, Vice President, Chief Clinical Innovation Officer of Mount Sinai Health System.</description><pubDate>Mon, 01 Jun 2026 04:42:00 GMT</pubDate></item><item><title>Wiley and OpenEvidence Partner to Deliver Trusted Research to ...</title><link>https://www.openevidence.com/announcements/wiley-and-openevidence-partner-to-deliver-trusted-research-to-physicians-at-the-point-of-care</link><description>HOBOKEN, N.J. – March 3, 2026 – Wiley (NYSE: WLY), a global leader in authoritative content and research intelligence for the advancement of clinical practice, scientific discovery and learning, and OpenEvidence, the most widely used medical AI platform in the world, today announced a strategic partnership to bring Wiley's trusted scientific and medical content into OpenEvidence. Through ...</description><pubDate>Sun, 31 May 2026 04:00:00 GMT</pubDate></item></channel></rss>